What is William Blair’s Estimate for LFST FY2024 Earnings?

LifeStance Health Group, Inc. (NASDAQ:LFST) – Stock analysts at William Blair boosted their FY2024 earnings estimates for LifeStance Health Group in a research report issued on Thursday, November 7th. William Blair analyst R. Daniels now forecasts that the company will post earnings of ($0.17) per share for the year, up from their prior forecast of ($0.26). The consensus estimate for LifeStance Health Group’s current full-year earnings is ($0.22) per share. William Blair also issued estimates for LifeStance Health Group’s Q4 2024 earnings at ($0.03) EPS.

Several other brokerages also recently issued reports on LFST. Barclays boosted their price target on shares of LifeStance Health Group from $6.00 to $7.00 and gave the company an “underweight” rating in a report on Monday. UBS Group cut their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $8.42.

LifeStance Health Group Stock Up 0.4 %

Shares of LifeStance Health Group stock opened at $7.39 on Monday. The stock has a market capitalization of $2.83 billion, a price-to-earnings ratio of -28.42 and a beta of 1.24. LifeStance Health Group has a twelve month low of $4.64 and a twelve month high of $9.20. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.20. The business’s 50 day simple moving average is $6.94 and its 200-day simple moving average is $6.22.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.05. The business had revenue of $312.70 million during the quarter, compared to analyst estimates of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.67%. The company’s quarterly revenue was up 18.9% on a year-over-year basis. During the same period in the previous year, the business posted ($0.17) EPS.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of LFST. Vanguard Group Inc. raised its position in shares of LifeStance Health Group by 1.3% during the first quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company’s stock worth $47,318,000 after purchasing an additional 95,197 shares during the period. Principal Financial Group Inc. increased its position in shares of LifeStance Health Group by 6.1% in the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock worth $28,817,000 after acquiring an additional 235,316 shares in the last quarter. Jennison Associates LLC raised its holdings in shares of LifeStance Health Group by 9.5% during the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock valued at $14,959,000 after acquiring an additional 184,896 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of LifeStance Health Group by 82.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock valued at $4,991,000 after acquiring an additional 457,930 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in LifeStance Health Group in the 2nd quarter worth approximately $4,326,000. Institutional investors own 85.50% of the company’s stock.

Insiders Place Their Bets

In other news, insider Ann Varanakis sold 5,269 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total value of $33,089.32. Following the sale, the insider now owns 263,007 shares of the company’s stock, valued at approximately $1,651,683.96. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 6.60% of the stock is currently owned by insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.